参考文献/References:
[1] Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues[M]. 4th ed. Lyon:IARC, 2008.
[2] Cerci JJ, Trindade E, Pracchia LF, et al. Cost effectiveness of positron emission tomography in patients with Hodgkin’s lymphoma in unconfirmed complete remission or partial remission after first-line therapy[J]. J Clin Oncol, 2010, 28(8):1415-1421. DOI:10.1200/JCO. 2009. 25. 4367.
[3] Baba S, Abe K, Isoda T, et al. Impact of FDG-PET/CT in the management of lymphoma[J]. Ann Nucl Med, 2011, 25(10):701-716. DOI:10.1007/s12149-011-0549-0.
[4] Barrington SF, Mikhaeel NG, Kostakoglu L, et al. Role of imaging in the staging and response assessment of lymphoma:consensus of the International Conference on Malignant Lymphomas Imaging Working Group[J]. J Clin Oncol, 2014, 32(27):3048-3058. DOI:10.1200/JCO. 2013. 53. 5229.
[5] Meignan M, Gallamini A, Haioun C, et al. Report on the Second International Workshop on interim positron emission tomography in lymphoma held in Menton, France, 8-9 April 2010[J]. Leuk Lymphoma, 2010, 51(12):2171-2180. DOI:10. 3109/10428194. 2010. 529208.
[6] Meignan M, Gallamini A, Itti E, et al. Report on the Third International Workshop on Interim Positron Emission Tomography in Lymphoma held in Menton, France, 26-27 September 2011 and Menton 2011 consensus[J]. Leuk Lymphoma, 2012, 53(10):1876-1881. DOI:10. 3109/10428194. 2012. 677535.
[7] Barrington SF, Qian W, Somer EJ, et al. Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma[J]. Eur J Nucl Med Mol Imaging, 2010, 37(10):1824-1833. DOI:10.1007/s00259-010-1490-5.
[8] Dann EJ. PET/CT adapted therapy in Hodgkin disease:current state of the art and future directions[J]. Curr Oncol Rep, 2012, 14(5):403-410. DOI:10.1007/s11912-012-0250-z.
[9] 覃春霞, 兰晓莉. PET/CT在恶性淋巴瘤疗效评估中的应用[J]. 临床内科杂志, 2015, 32(3):166-169. DOI:10.3969/j.issn.1001-9057.2015.03.006. Qin CX,Lan XL. Application of PET/CT in evaluation of curative effect of lymphoma[J]. J Clin Int Med, 2015,32(3):166-169.
[10] Kasamon YL, Jones RJ, Wahl RL. Integrating PET and PET/CT into the risk-adapted therapy of lymphoma[J]. J Nucl Med, 2007, 48 Suppl 1:S19-27.
[11] 陈伟华, 冷吉艳. 18F-FDG PET-CT显像对恶性淋巴瘤诊断和分期中的临床应用价值[J]. 中国实验诊断学, 2010, 14(5):682-684. DOI:10. 3969/j. issn. 1007-4287. 2010. 05. 016. Chen WH, Leng JY. Clinical utility of 18F-FDG PET-CT in diagnosis and staging of lymphoma[J]. Chin J Lab Diagn, 2010, 14(5):682-684.
[12] 林端瑜, 唐明灯, 李生栩, 等. 18F-FDG PET-CT在霍奇金淋巴瘤疗效评价中的临床价值[J]. 国际放射医学核医学杂志, 2012, 36(6):352-357. DOI:10. 3760/cma. j. issn. 1673-4114. 2012. 06. 008. Lin DY, Tang MD, Li SX, et al. A preliminary study on clinical value of 18F-FDG PET-CT in evaluation of efficacy of Hodgkin lymphoma[J]. Int J Radiat Med Nucl Med, 2012, 36(6):352-357.
[13] Castellucci P, Zinzani P, Pourdehnad M, et al. 18F-FDG PET in malignant lymphoma:significance of positive findings[J]. Eur J Nucl Med Mol Imaging, 2005, 32(7):749-756. DOI:10.1007/s00259-004-1748-x.
[14] 宋玉琴, 朱军. PET/CT在淋巴瘤中的应用价值[J]. 中华医学杂志, 2012, 92(46):3241-3242. DOI:10. 3760/cma. j. issn. 0376-2491. 2012. 46. 001. Song YQ, Zhu J. The application value of PET/CT in lymphoma[J]. Natl Med J China, 2012, 92(46):3241-3242.
相似文献/References:
[1]尤阳,轩昂,张杰,等.淋巴瘤患者大脑静息葡萄糖代谢改变[J].国际放射医学核医学杂志,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
You Yang,Xuan Ang,Zhang Jie,et al.Changes in resting-state brain glucose metabolism in patients with lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
[2]王朋,崔邦平,代文莉,等.18F-FDG PET/CT在前列腺癌中的应用进展[J].国际放射医学核医学杂志,2016,40(4):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
Wang Peng,Cui Bangping,Dai Wenli,et al.Progress in the application of 18F-FDG PET/CT in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
[3]李菲,黄俊星,张俊.18F-FDG PET/CT在食管癌中的临床应用[J].国际放射医学核医学杂志,2016,40(4):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]
Li Fei,Huang Junxing,Zhang Jun.The clinical application of 18F-FDG PET/CT in esophageal cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]
[4]许靖,李肖红,秦永德,等.帕金森病脑部葡萄糖代谢和脑多巴胺转运体PET显像特点的临床研究[J].国际放射医学核医学杂志,2016,40(5):338.[doi:10.3760/cma.j.issn.1673-4114.2016.05.003]
Xu Jing,Li Xiaohong,Qin Yongde,et al.Clinical study of brain glucose metabolism and brain dopamine transporter PET imaging in patients with Parkinson’s disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):338.[doi:10.3760/cma.j.issn.1673-4114.2016.05.003]
[5]曹登敏,林美福,陈文新,等.继发性骨淋巴瘤的18F-FDG PET/CT影像学表现[J].国际放射医学核医学杂志,2016,40(6):403.[doi:10.3760/cma.j.issn.1673-4114.2016.06.001]
Cao Dengmin,Lin Meifu,Chen Wenxin,et al.Analysis on 18F-FDG PET/CT imaging characteristics in secondary bone lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):403.[doi:10.3760/cma.j.issn.1673-4114.2016.06.001]
[6]李生栩,唐明灯,林端瑜,等.18F-FDG PET/CT在胸段食管鳞癌淋巴结转移中的诊断价值[J].国际放射医学核医学杂志,2016,40(6):408.[doi:10.3760/cma.j.issn.1673-4114.2016.06.002]
Li Shengxu,Tang Mingdeng,Lin Duanyu,et al.Value of 18F-FDG PET/CT in detecting metastatic lymph nodes of thoracic esophageal squamous cell carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):408.[doi:10.3760/cma.j.issn.1673-4114.2016.06.002]
[7]张莹莹,王振光,武凤玉,等.特发性肺间质纤维化HRCT病变区与非病变区18F-FDG PET/CT表现分析[J].国际放射医学核医学杂志,2016,40(6):414.[doi:10.3760/cma.j.issn.1673-4114.2016.06.003]
Zhang Yingying,Wang Zhenguang,Wu Fengyu,et al.18F-FDG PET/CT imaging analysis of regions with abnormal and normal pulmonary parenchyma on high resolution CT in idiopathic pulmonary fibrosis patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):414.[doi:10.3760/cma.j.issn.1673-4114.2016.06.003]
[8]张毓艺,姚稚明.18F-FDG PET/CT对非小细胞肺癌淋巴结分期诊断价值的研究进展[J].国际放射医学核医学杂志,2016,40(6):447.[doi:10.3760/cma.j.issn.1673-4114.2016.06.009]
Zhang Yuyi,Yao Zhiming.The progress of 18F-FDG PET/CT in the diagnosis of N-staging of non-small cell lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):447.[doi:10.3760/cma.j.issn.1673-4114.2016.06.009]
[9]郝新忠,武志芳,武萍,等.SAPHO综合征18F-FDG PET/CT显像和临床分析[J].国际放射医学核医学杂志,2015,39(6):447.[doi:10.3760/cma.j.issn.1673-4114.2015.06.003]
Hao Xinzhong,Wu Zhifang,Wu Ping,et al.18F-FDG PET/CT imaging and clinical features of SAPHO syndrome[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):447.[doi:10.3760/cma.j.issn.1673-4114.2015.06.003]
[10]邱琳,陈跃,黄占文,等.18F-FDG PET/CT脑显像在新生儿缺血缺氧性脑病诊断及治疗后评估中的临床研究[J].国际放射医学核医学杂志,2015,39(6):452.[doi:10.3760/cma.j.issn.1673-4114.2015.06.004]
Qiu Lin,Chen Yue,Huang Zhanwen,et al.Clinical research on using 18F-FDG PET/CT brain imaging in the diagnosis of and therapeutic effect evaluation in neonatal hypoxic-ischemic encephalopathy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):452.[doi:10.3760/cma.j.issn.1673-4114.2015.06.004]
[11]林端瑜,唐明灯,李生栩,等.18F-FDG PET-CT在霍奇金淋巴瘤疗效评价中的临床价值[J].国际放射医学核医学杂志,2012,36(6):352.[doi:10.3760/cma.j.issn.1673-4114.2012.06.008]
LIN Duan-yu,TANG Ming-deng,LI Sheng-xu,et al.A preliminary study on clinical value of 18F-FDG PET-CT in evaluation of efficacy of Hodgkin lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(2):352.[doi:10.3760/cma.j.issn.1673-4114.2012.06.008]